{"transactions":[{"id":737711,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38148,"kind":"person","name":"Sainz Maria","position":1,"cik":"0001437768","reported_name":"Sainz Maria","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2026-06-16T00:54:57.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":3793,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest in equal quarterly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on September 5, 2026."}],"balance_after":3793,"derivative":{"exercise_price":26.89,"expiration_date":"2036-06-11","underlying":"Common Stock","underlying_shares":3793},"source":{"system":"sec-edgar","filing":"0001437749-26-020713","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1437768/000143774926020713/rdgdoc.xml","form_type":"4"}},{"id":737710,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38148,"kind":"person","name":"Sainz Maria","position":1,"cik":"0001437768","reported_name":"Sainz Maria","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2026-06-16T00:54:57.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in equal monthly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on July 11, 2026."}],"balance_after":30000,"derivative":{"exercise_price":26.89,"expiration_date":"2036-06-11","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001437749-26-020713","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437768/000143774926020713/rdgdoc.xml","form_type":"4"}},{"id":822769,"issuer":{"id":6865,"kind":"organization","name":"Hyperfine, Inc."},"owners":[{"id":38148,"kind":"person","name":"Sainz Maria","position":1,"cik":"0001437768","reported_name":"Sainz Maria","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2026-04-01T20:56:53.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":750000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consist of restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of Class A common stock upon vesting. The RSUs vest 25% on March 23, 2027, with the remainder vesting in equal quarterly installments over the following three years, subject to Ms. Sainz's continued service through the applicable vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Consists of 750,000 RSUs granted on March 31, 2026 plus 19,586 shares received on vesting of an RSU award granted on December 23, 2021 and an aggregate of 20,000 purchased shares."}],"balance_after":789586,"source":{"system":"sec-edgar","filing":"0001193125-26-138139","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437768/000119312526138139/ownership.xml","form_type":"4"}},{"id":915918,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38148,"kind":"person","name":"Sainz Maria","position":1,"cik":"0001437768","reported_name":"Sainz Maria","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2026-02-07T02:21:10.000Z","date":"2026-02-05","kind":"grant","planned":false,"acquired":true,"shares":3104,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest in equal installments on March 5, 2026 and June 5, 2026, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":3104,"derivative":{"exercise_price":13.69,"expiration_date":"2036-02-05","underlying":"Common Stock","underlying_shares":3104},"source":{"system":"sec-edgar","filing":"0001437749-26-003395","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1437768/000143774926003395/rdgdoc.xml","form_type":"4"}},{"id":915917,"issuer":{"id":1151,"kind":"organization","name":"PULSE BIOSCIENCES, INC.","symbol":"PLSE"},"owners":[{"id":38148,"kind":"person","name":"Sainz Maria","position":1,"cik":"0001437768","reported_name":"Sainz Maria","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2026-02-07T02:21:10.000Z","date":"2026-01-08","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the shares subject to the option will vest on the one-year anniversary of the grant and the remaining shares will vest on a monthly basis over two years thereafter, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":50000,"derivative":{"exercise_price":14.72,"expiration_date":"2036-01-08","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001437749-26-003395","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437768/000143774926003395/rdgdoc.xml","form_type":"4"}},{"id":1496611,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":38148,"kind":"person","name":"Sainz Maria","position":1,"cik":"0001437768","reported_name":"Sainz Maria","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-31T20:38:26.000Z","date":"2024-05-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":5328,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Form 4 reports the disposition of securities pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of April 4, 2024, by and among the Issuer, Johnson & Johnson (\"J&J\"), and Sweep Merger Sub, Inc., a wholly owned subsidiary of J&J (\"Merger Sub\"), pursuant to which Merger Sub merged with and into the Issuer (the \"Merger\"), effective as of the effective time of the Merger (the \"Effective Time\"), with the Issuer surviving the Merger as a wholly owned subsidiary of J&J. As a result of the Merger, at the Effective Time, each outstanding share of common stock, par value $0.001 per share, of the Issuer (\"Common Stock\") outstanding immediately prior to the Effective Time (excluding Excluded Shares and any Dissenting Company Shares, each as defined in the Merger Agreement) was automatically converted into the right to receive $335.00 in cash (the \"Merger Consideration\"),"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(Continued from Footnote 1) without interest and less any applicable withholding taxes.  Additionally, pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit (\"RSU\") outstanding immediately prior to the Effective Time, whether vested or unvested, was cancelled and converted into the right to receive a cash amount, without interest and less any applicable withholding taxes, equal to the product of (i) the aggregate number of shares of Common Stock underlying such RSU immediately prior to the Effective Time and (ii) the Merger Consideration."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001642545-24-000118","document":"wk-form4_1717187671.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437768/000164254524000118/wk-form4_1717187671.xml","form_type":"4"}},{"id":1558332,"issuer":{"id":6865,"kind":"organization","name":"Hyperfine, Inc."},"owners":[{"id":38148,"kind":"person","name":"Sainz Maria","position":1,"cik":"0001437768","reported_name":"Sainz Maria","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2024-03-28T22:28:55.000Z","date":"2024-03-28","kind":"grant","planned":false,"acquired":true,"shares":1435000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares underlying this option vest as to 25% on March 28, 2025, with the remainder vesting in 36 equal monthly installments thereafter, subject to Ms. Sainz's continued service through the applicable vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest as to 25% on March 28, 2025, with the remainder vesting in 36 equal monthly installments thereafter, subject to Ms. Sainz's continued service through the applicable vesting date."}],"balance_after":1435000,"derivative":{"exercise_price":1,"expiration_date":"2034-03-28","underlying":"Class A Common Stock","underlying_shares":1435000},"source":{"system":"sec-edgar","filing":"0001209191-24-005126","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437768/000120919124005126/doc4.xml","form_type":"4"}},{"id":1854204,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":38148,"kind":"person","name":"Sainz Maria","position":1,"cik":"0001437768","reported_name":"Sainz Maria","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-15T22:53:39.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":736,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5328,"source":{"system":"sec-edgar","filing":"0001209191-23-037559","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437768/000120919123037559/doc4.xml","form_type":"4"}},{"id":1993009,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":38148,"kind":"person","name":"Sainz Maria","position":1,"cik":"0001437768","reported_name":"Sainz Maria","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-25T01:24:54.000Z","date":"2023-02-23","kind":"sale","acquired":false,"shares":724,"price":193,"value":139732.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"All reported securities were sold at a price of $193.00."}],"balance_after":4592,"source":{"system":"sec-edgar","filing":"0001209191-23-012988","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437768/000120919123012988/doc4.xml","form_type":"4"}},{"id":2086385,"issuer":{"id":6865,"kind":"organization","name":"Hyperfine, Inc."},"owners":[{"id":38148,"kind":"person","name":"Sainz Maria","position":1,"cik":"0001437768","reported_name":"Sainz Maria","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2022-12-14T21:59:10.000Z","date":"2022-12-14","kind":"purchase","acquired":true,"shares":5000,"price":0.95,"value":4750.0,"ownership":{"direct":true},"balance_after":39425,"source":{"system":"sec-edgar","filing":"0001209191-22-061247","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437768/000120919122061247/doc4.xml","form_type":"4"}},{"id":2089562,"issuer":{"id":6865,"kind":"organization","name":"Hyperfine, Inc."},"owners":[{"id":38148,"kind":"person","name":"Sainz Maria","position":1,"cik":"0001437768","reported_name":"Sainz Maria","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2022-12-12T23:56:49.000Z","date":"2022-12-09","kind":"purchase","acquired":true,"shares":12425,"price":0.85,"value":10561.25,"ownership":{"direct":true},"balance_after":34425,"source":{"system":"sec-edgar","filing":"0001209191-22-060775","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437768/000120919122060775/doc4a.xml","form_type":"4/A","original_submission_date":"2022-12-12"}},{"id":2089561,"issuer":{"id":6865,"kind":"organization","name":"Hyperfine, Inc."},"owners":[{"id":38148,"kind":"person","name":"Sainz Maria","position":1,"cik":"0001437768","reported_name":"Sainz Maria","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2022-12-12T23:56:00.000Z","date":"2022-12-08","kind":"purchase","acquired":true,"shares":2575,"price":0.83,"value":2137.25,"ownership":{"direct":true},"balance_after":22161,"source":{"system":"sec-edgar","filing":"0001209191-22-060774","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437768/000120919122060774/doc4a.xml","form_type":"4/A","original_submission_date":"2022-12-08"}},{"id":2089560,"issuer":{"id":6865,"kind":"organization","name":"Hyperfine, Inc."},"owners":[{"id":38148,"kind":"person","name":"Sainz Maria","position":1,"cik":"0001437768","reported_name":"Sainz Maria","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2022-12-12T21:05:24.000Z","date":"2022-12-09","kind":"grant","acquired":true,"shares":12425,"price":0.85,"value":10561.25,"ownership":{"direct":true},"balance_after":34425,"source":{"system":"sec-edgar","filing":"0001209191-22-060673","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437768/000120919122060673/doc4.xml","form_type":"4"}},{"id":2092169,"issuer":{"id":6865,"kind":"organization","name":"Hyperfine, Inc."},"owners":[{"id":38148,"kind":"person","name":"Sainz Maria","position":1,"cik":"0001437768","reported_name":"Sainz Maria","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Class A Common Stock","published_at":"2022-12-08T22:54:54.000Z","date":"2022-12-08","kind":"grant","acquired":true,"shares":2575,"price":0.83,"value":2137.25,"ownership":{"direct":true},"balance_after":22161,"source":{"system":"sec-edgar","filing":"0001209191-22-060389","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437768/000120919122060389/doc4.xml","form_type":"4"}},{"id":2128375,"issuer":{"id":6865,"kind":"organization","name":"Hyperfine, Inc."},"owners":[{"id":38148,"kind":"person","name":"Sainz Maria","position":1,"cik":"0001437768","reported_name":"Sainz Maria","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2022-11-01T21:51:07.000Z","date":"2022-10-31","kind":"grant","acquired":true,"shares":3175000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares underlying this option vest as to 25% on October 24, 2023, with the remainder vesting in 36 equal monthly installments thereafter, subject to Ms. Sainz's continued service through the applicable vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest as to 25% on October 24, 2023, with the remainder vesting in 36 equal monthly installments thereafter, subject to Ms. Sainz's continued service through the applicable vesting date."}],"balance_after":3175000,"derivative":{"exercise_price":0.91,"expiration_date":"2032-10-24","underlying":"Class A Common Stock","underlying_shares":3175000},"source":{"system":"sec-edgar","filing":"0001209191-22-055102","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437768/000120919122055102/doc4.xml","form_type":"4"}},{"id":2162214,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":38148,"kind":"person","name":"Sainz Maria","position":1,"cik":"0001437768","reported_name":"Sainz Maria","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-09-10T00:05:47.000Z","date":"2022-09-08","kind":"sale","acquired":false,"shares":650,"price":295,"value":191750.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"All reported securities were sold at a price of $295.00."}],"balance_after":5316,"source":{"system":"sec-edgar","filing":"0001209191-22-049366","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437768/000120919122049366/doc4.xml","form_type":"4"}},{"id":2221081,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":38148,"kind":"person","name":"Sainz Maria","position":1,"cik":"0001437768","reported_name":"Sainz Maria","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-28T00:01:43.000Z","date":"2022-06-23","kind":"grant","acquired":true,"shares":994,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5966,"source":{"system":"sec-edgar","filing":"0001209191-22-039544","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437768/000120919122039544/doc4.xml","form_type":"4"}},{"id":2234061,"issuer":{"id":6865,"kind":"organization","name":"Hyperfine, Inc."},"owners":[{"id":38148,"kind":"person","name":"Sainz Maria","position":1,"cik":"0001437768","reported_name":"Sainz Maria","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2022-06-13T20:10:51.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":85345,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest on the date of the Issuer's next regular annual stockholders meeting, subject to Ms. Sainz's continued service through the applicable vesting date."}],"balance_after":85345,"derivative":{"exercise_price":2.2,"expiration_date":"2032-06-09","underlying":"Class A Common Stock","underlying_shares":85345},"source":{"system":"sec-edgar","filing":"0001209191-22-036280","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437768/000120919122036280/doc4.xml","form_type":"4"}},{"id":2256133,"issuer":{"id":88164,"kind":"organization","name":"ATRION CORP","symbol":"ATRI"},"owners":[{"id":38148,"kind":"person","name":"Sainz Maria","position":1,"cik":"0001437768","reported_name":"Sainz Maria","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-26T12:32:40.000Z","date":"2022-05-24","kind":"grant","acquired":true,"shares":172,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Issuer's director compensation policy provides for a grant to the Reporting Person of an award of common stock in an amount equal to $108,000.  On May 24, 2022 the Compensation Committee granted an award to each independent director in an annual amount equal to $108,000."},{"field":"shares","element":"transactionShares","label":"F2","text":"The number of shares of common stock granted for all of the awards described above was based on the closing price per share of the Issuer's common stock on May 24, 2022, or $624.50"}],"balance_after":284,"source":{"system":"sec-edgar","filing":"0001437768-22-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/701288/000143776822000004/primary_doc.xml","form_type":"4"}},{"id":2438835,"issuer":{"id":6865,"kind":"organization","name":"Hyperfine, Inc."},"owners":[{"id":38148,"kind":"person","name":"Sainz Maria","position":1,"cik":"0001437768","reported_name":"Sainz Maria","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2022-01-11T02:37:42.000Z","date":"2021-12-23","kind":"grant","acquired":true,"shares":19586,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in equal annual installments over three years beginning on December 23, 2022, subject to Ms. Sainz's continued service through the applicable vesting date."}],"balance_after":19586,"source":{"system":"sec-edgar","filing":"0001104659-22-002886","document":"tm222483-1_4aseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437768/000110465922002886/tm222483-1_4aseq1.xml","form_type":"4/A","original_submission_date":"2021-12-23"}},{"id":2443670,"issuer":{"id":28189,"kind":"organization","name":"AVANOS MEDICAL, INC.","symbol":"AVNS"},"owners":[{"id":38148,"kind":"person","name":"Sainz Maria","position":1,"cik":"0001437768","reported_name":"Sainz Maria","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-05T14:53:49.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":5354,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted share units issued to the reporting person on January 3, 2022 pursuant to the Avanos Medical, Inc. Outside Directors' Compensation Plan."}],"balance_after":33396,"source":{"system":"sec-edgar","filing":"0001606498-22-000013","document":"wf-form4_164139441567536.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437768/000160649822000013/wf-form4_164139441567536.xml","form_type":"4"}},{"id":2452551,"issuer":{"id":88164,"kind":"organization","name":"ATRION CORP","symbol":"ATRI"},"owners":[{"id":38148,"kind":"person","name":"Sainz Maria","position":1,"cik":"0001437768","reported_name":"Sainz Maria","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-04T16:27:09.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":18,"price":704.9,"value":12688.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"(1)Acquisition of shares at fair market value in lieu of certain cash fees pursuant to the Atrion Corporation Non-Employee Director Stock Purchase Plan."}],"balance_after":112,"source":{"system":"sec-edgar","filing":"0001437768-22-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/701288/000143776822000001/primary_doc.xml","form_type":"4"}},{"id":2459496,"issuer":{"id":6865,"kind":"organization","name":"Hyperfine, Inc."},"owners":[{"id":38148,"kind":"person","name":"Sainz Maria","position":1,"cik":"0001437768","reported_name":"Sainz Maria","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-12-24T02:41:25.000Z","date":"2021-12-23","kind":"grant","acquired":true,"shares":16483,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in equal annual installments over three years beginning on December 23, 2022, subject to Ms. Sainz's continued service through the applicable vesting date."}],"balance_after":16483,"source":{"system":"sec-edgar","filing":"0001104659-21-153331","document":"tm2135698-14_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437768/000110465921153331/tm2135698-14_4seq1.xml","form_type":"4"}},{"id":2584356,"issuer":{"id":88164,"kind":"organization","name":"ATRION CORP","symbol":"ATRI"},"owners":[{"id":38148,"kind":"person","name":"Sainz Maria","position":1,"cik":"0001437768","reported_name":"Sainz Maria","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-01T14:29:05.000Z","date":"2021-08-30","kind":"grant","acquired":true,"shares":94,"price":703.63,"value":66141.22,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Issuer's director compensation policy provides for a grant to the Reporting Person of an annual award of common stock in an amount equal to $92,000.  On August 30, 2021,  the Compensation Committee granted an award to Ms. Maria Sainz in an amount equal to $66,290 which is the pro rated portion of the annual amount for the remaining portion of the year until the Annual Stockholders meeting."},{"field":"shares","element":"transactionShares","label":"F2","text":"The number of shares of common stock issued for the award described above was based on the closing price per share of the Issuer's common stock on August 30, 2021, or $703.63."}],"balance_after":94,"source":{"system":"sec-edgar","filing":"0001437768-21-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/701288/000143776821000001/primary_doc.xml","form_type":"4"}},{"id":2636943,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":38148,"kind":"person","name":"Sainz Maria","position":1,"cik":"0001437768","reported_name":"Sainz Maria","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-10T01:41:40.000Z","date":"2021-06-28","kind":"grant","acquired":true,"shares":850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The shares subject to the restricted stock units vest on 6/25/2022, subject to the Reporting Person's continued service through such date."}],"balance_after":4972,"source":{"system":"sec-edgar","filing":"0000950103-21-010317","document":"dp154195_4-sainz.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437768/000095010321010317/dp154195_4-sainz.xml","form_type":"4"}},{"id":2915339,"issuer":{"id":28189,"kind":"organization","name":"AVANOS MEDICAL, INC.","symbol":"AVNS"},"owners":[{"id":38148,"kind":"person","name":"Sainz Maria","position":1,"cik":"0001437768","reported_name":"Sainz Maria","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-06T15:18:25.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":4005,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted share units issued to the reporting person on January 4, 2021 pursuant to the Avanos Medical, Inc. Outside Directors' Compensation Plan."}],"balance_after":28042,"source":{"system":"sec-edgar","filing":"0001606498-21-000002","document":"wf-form4_160994629216829.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437768/000160649821000002/wf-form4_160994629216829.xml","form_type":"4"}},{"id":3079514,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":38148,"kind":"person","name":"Sainz Maria","position":1,"cik":"0001437768","reported_name":"Sainz Maria","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-07-20T20:50:33.000Z","date":"2020-07-16","kind":"grant","acquired":true,"shares":4122,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the issuer's common stock. The shares subject to the restricted stock units vest in equal annual installments over three years commencing on July 16, 2020, subject to the Reporting Person's continued service through each relevant vesting date."}],"balance_after":4122,"source":{"system":"sec-edgar","filing":"0000950103-20-013899","document":"dp132549_4-sainz.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437768/000095010320013899/dp132549_4-sainz.xml","form_type":"4"}},{"id":3115344,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":38148,"kind":"person","name":"Sainz Maria","position":1,"cik":"0001437768","reported_name":"Sainz Maria","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-10T21:59:02.000Z","date":"2020-06-08","kind":"grant","acquired":true,"shares":4588,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Deferred Stock Unit award subject to deferred distribution after termination of service as a director of the Issuer, an exempt transaction pursuant to Rule 16b-3(d) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"). The award vests in full on the first anniversary of the grant date, June 8, 2020."}],"balance_after":40871,"source":{"system":"sec-edgar","filing":"0001209191-20-035655","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/884624/000120919120035655/doc4.xml","form_type":"4"}},{"id":3315204,"issuer":{"id":28189,"kind":"organization","name":"AVANOS MEDICAL, INC.","symbol":"AVNS"},"owners":[{"id":38148,"kind":"person","name":"Sainz Maria","position":1,"cik":"0001437768","reported_name":"Sainz Maria","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-08T21:19:52.000Z","date":"2020-01-02","kind":"grant","acquired":true,"shares":5293,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted share units issued to the reporting person on January 2, 2020 pursuant to the Avanos Medical, Inc. Outside Director's Compensation Plan."}],"balance_after":24037,"source":{"system":"sec-edgar","filing":"0001606498-20-000006","document":"wf-form4_157851837459823.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437768/000160649820000006/wf-form4_157851837459823.xml","form_type":"4"}},{"id":3456223,"issuer":{"id":7882,"kind":"organization","name":"IRIDEX CORP","symbol":"IRIX"},"owners":[{"id":38148,"kind":"person","name":"Sainz Maria","position":1,"cik":"0001437768","reported_name":"Sainz Maria","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-25T23:08:50.000Z","date":"2019-07-23","kind":"grant","acquired":true,"shares":11204,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a restricted stock unit (RSU). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. 100% of the RSUs vest on the earlier of July 23, 2020 or the date of the Issuer's next annual meeting of stockholders."}],"balance_after":16894,"source":{"system":"sec-edgar","filing":"0001209191-19-043280","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006045/000120919119043280/doc4.xml","form_type":"4"}},{"id":3491894,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":38148,"kind":"person","name":"Sainz Maria","position":1,"cik":"0001437768","reported_name":"Sainz Maria","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-13T22:02:16.000Z","date":"2019-06-11","kind":"grant","acquired":true,"shares":3431,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Deferred Stock Unit award subject to deferred distribution after termination of service as a director of the Issuer, an exempt transaction pursuant to Rule 16b-3(d) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"). The award vests in full on the first anniversary of the grant date, June 11, 2019."}],"balance_after":35833,"source":{"system":"sec-edgar","filing":"0001209191-19-036918","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/884624/000120919119036918/doc4.xml","form_type":"4"}},{"id":3703855,"issuer":{"id":28189,"kind":"organization","name":"AVANOS MEDICAL, INC.","symbol":"AVNS"},"owners":[{"id":38148,"kind":"person","name":"Sainz Maria","position":1,"cik":"0001437768","reported_name":"Sainz Maria","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-01-04T14:46:27.000Z","date":"2019-01-02","kind":"grant","acquired":true,"shares":4248,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted share units issued to the reporting person on January 2, 2019, pursuant to the Avanos Medical, Inc. Outside Directors' Compensation Plan."}],"balance_after":18744,"source":{"system":"sec-edgar","filing":"0001606498-19-000008","document":"wf-form4_154661317000482.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437768/000160649819000008/wf-form4_154661317000482.xml","form_type":"4"}},{"id":3866732,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":38148,"kind":"person","name":"Sainz Maria","position":1,"cik":"0001437768","reported_name":"Sainz Maria","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-17T23:02:30.000Z","date":"2018-07-17","kind":"grant","acquired":true,"shares":2900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Deferred Stock Unit award granted on July 2, 2018, subject to shareholder approval, which was obtained on July 17, 2018, and is subject to\ndeferred distribution after termination of service as a director of the Issuer, an exempt transaction pursuant to Rule 16b-3(d) under the Securities\nExchange Act of 1934, as amended (the \"Exchange Act\"). These awards vest in full on July 2, 2019."}],"balance_after":32167,"source":{"system":"sec-edgar","filing":"0001209191-18-042922","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/884624/000120919118042922/doc4.xml","form_type":"4"}},{"id":3892923,"issuer":{"id":7882,"kind":"organization","name":"IRIDEX CORP","symbol":"IRIX"},"owners":[{"id":38148,"kind":"person","name":"Sainz Maria","position":1,"cik":"0001437768","reported_name":"Sainz Maria","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-16T00:10:37.000Z","date":"2018-06-13","kind":"grant","acquired":true,"shares":5690,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a restricted stock unit (RSU).  Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. 100% of the RSUs vest on the earlier of June 13, 2019 or the date of the Issuer's next annual meeting of stockholders."}],"balance_after":5690,"source":{"system":"sec-edgar","filing":"0001704739-18-000028","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006045/000170473918000028/edgar.xml","form_type":"4"}},{"id":3945521,"issuer":{"id":28189,"kind":"organization","name":"AVANOS MEDICAL, INC.","symbol":"AVNS"},"owners":[{"id":38148,"kind":"person","name":"Sainz Maria","position":1,"cik":"0001437768","reported_name":"Sainz Maria","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-04T14:38:38.000Z","date":"2018-05-03","kind":"grant","acquired":true,"shares":384,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted share units issued to the reporting person on May 3, 2018 pursuant to the Halyard Health, Inc. Outside Director's Compensation Plan."}],"balance_after":14496,"source":{"system":"sec-edgar","filing":"0001606498-18-000041","document":"wf-form4_152544466951497.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437768/000160649818000041/wf-form4_152544466951497.xml","form_type":"4"}},{"id":3962547,"issuer":{"id":7882,"kind":"organization","name":"IRIDEX CORP","symbol":"IRIX"},"owners":[{"id":38148,"kind":"person","name":"Sainz Maria","position":1,"cik":"0001437768","reported_name":"Sainz Maria","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-04-17T21:45:06.000Z","date":"2018-04-13","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The option was granted pursuant to IRIDEX Corporation's 2008 Amended and Restated Equity Incentive Plan and is exempt pursuant to Rule 16b-3."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares are subject to vesting according to the following schedule: 1/48th of the total number of shares vest on May 13, 2018 and each month thereafter."}],"balance_after":15000,"derivative":{"exercise_price":5.69,"expiration_date":"2025-04-13","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001704739-18-000009","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006045/000170473918000009/edgar.xml","form_type":"4"}},{"id":3976356,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":38148,"kind":"person","name":"Sainz Maria","position":1,"cik":"0001437768","reported_name":"Sainz Maria","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-04-02T20:58:49.000Z","date":"2018-03-30","kind":"grant","acquired":true,"shares":918,"price":3.13,"value":2873.34,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares were issued pursuant to the issuer's Second Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at a price of $3.13 per share, representing the volume-weighted average price of the issuer's common stock for the five-trading day period ended March 29, 2018."}],"balance_after":918,"source":{"system":"sec-edgar","filing":"0001534424-18-000114","document":"sainz.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437768/000153442418000114/sainz.xml","form_type":"4"}},{"id":4111596,"issuer":{"id":28189,"kind":"organization","name":"AVANOS MEDICAL, INC.","symbol":"AVNS"},"owners":[{"id":38148,"kind":"person","name":"Sainz Maria","position":1,"cik":"0001437768","reported_name":"Sainz Maria","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-03T22:14:53.000Z","date":"2018-01-02","kind":"grant","acquired":true,"shares":2946,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted share units issued to the reporting person on January 2, 2018 pursuant to the Halyard Health, Inc. Outside Director's Compensation Plan."}],"balance_after":14112,"source":{"system":"sec-edgar","filing":"0001606498-18-000011","document":"wf-form4_151501767901653.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437768/000160649818000011/wf-form4_151501767901653.xml","form_type":"4"}},{"id":4131636,"issuer":{"id":2367,"kind":"organization","name":"ClearPoint Neuro, Inc.","symbol":"CLPT"},"owners":[{"id":38148,"kind":"person","name":"Sainz Maria","position":1,"cik":"0001437768","reported_name":"Sainz Maria","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2017-12-14T21:24:30.000Z","date":"2017-12-12","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option will vest in full on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2018 annual meeting of stockholders."}],"balance_after":15000,"derivative":{"exercise_price":2.75,"expiration_date":"2027-12-12","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001534424-17-000502","document":"sainz.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437768/000153442417000502/sainz.xml","form_type":"4"}},{"id":4237126,"issuer":{"id":173862,"kind":"organization","name":"SPECTRANETICS CORP","symbol":"SPNC"},"owners":[{"id":38148,"kind":"person","name":"Sainz Maria","position":1,"cik":"0001437768","reported_name":"Sainz Maria","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"SPNC Common Stock","published_at":"2017-08-11T14:33:01.000Z","date":"2017-08-09","kind":"disposition_to_issuer","acquired":false,"shares":34276,"price":38.5,"value":1319626.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Per the terms of the Agreement and Plan of Merger, dated as of June 27, 2017, among the Company, Philips Holding USA Inc., a Delaware corporation, and HealthTech Merger Sub, Inc., a Delaware corporation (the \"Merger Agreement\") and the Offer (as defined in the Merger Agreement), each share of Company common stock other than the restricted common stock described in Note 2 was validly tendered for $38.50 per share in cash, without interest and less any required withholding taxes."},{"field":"shares","element":"transactionShares","label":"F2","text":"Includes 4,780 shares of restricted common stock that, pursuant to their terms upon consummation of the Merger Agreement, were canceled at the Effective Time (as defined in the Merger Agreement) and converted into the right to receive $38.50 per share in cash, without interest."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001179110-17-011356","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/789132/000117911017011356/edgar.xml","form_type":"4"}},{"id":4260266,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":38148,"kind":"person","name":"Sainz Maria","position":1,"cik":"0001437768","reported_name":"Sainz Maria","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-07-10T21:58:23.000Z","date":"2017-07-03","kind":"grant","acquired":true,"shares":3579,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Deferred Stock Unit award subject to deferred distribution after termination of service as a director of the Issuer, an exempt transaction pursuant to Rule 16b-3(d) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"). These awards vest in full on July 3, 2018. Vested shares of common stock will be delivered to the reporting person within 45 days after termination of service as a director."}],"balance_after":28812,"source":{"system":"sec-edgar","filing":"0001209191-17-044653","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/884624/000120919117044653/doc4.xml","form_type":"4"}},{"id":4286404,"issuer":{"id":173862,"kind":"organization","name":"SPECTRANETICS CORP","symbol":"SPNC"},"owners":[{"id":38148,"kind":"person","name":"Sainz Maria","position":1,"cik":"0001437768","reported_name":"Sainz Maria","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"SPNC Common Stock","published_at":"2017-06-12T17:25:32.000Z","date":"2017-06-08","kind":"grant","acquired":true,"shares":4780,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Director compensation grant of SPNC restricted stock, vesting over 1 year, 100% vested on 6/8/2018."}],"balance_after":34276,"source":{"system":"sec-edgar","filing":"0000789132-17-000096","document":"wf-form4_149730271773746.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/789132/000078913217000096/wf-form4_149730271773746.xml","form_type":"4"}},{"id":4498414,"issuer":{"id":28189,"kind":"organization","name":"AVANOS MEDICAL, INC.","symbol":"AVNS"},"owners":[{"id":38148,"kind":"person","name":"Sainz Maria","position":1,"cik":"0001437768","reported_name":"Sainz Maria","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-05T14:27:49.000Z","date":"2017-01-03","kind":"grant","acquired":true,"shares":3749,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted share units issued to the reporting person on January 3, 2017 pursuant to the Halyard Health, Inc. Outside Director's Compensation Plan."}],"balance_after":11166,"source":{"system":"sec-edgar","filing":"0001606036-17-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1437768/000160603617000002/primary_doc.xml","form_type":"4"}}]}